Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
LRMR
LRMR News & Events
-
Add to Watchlist
Trade LRMR Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
LRMR News
Investigation Launched into Larimar Therapeutics for Possible Securities Fraud
13h ago
Globenewswire
Larimar Therapeutics Regulatory Progress Highlights Value Potential
5d ago
stocktwits
Pomerantz LLP Investigates Securities Fraud Claims Against Larimar Therapeutics
6d ago
PRnewswire
Larimar Submits Biologics License Application for Nomlabofusp
Jun 29 2026
NASDAQ.COM
Larimar Submits Biologics License Application for Friedreich's Ataxia Treatment
Jun 29 2026
stocktwits
Larimar Submits Biologics License Application for Nomlabofusp
Jun 29 2026
Newsfilter
Larimar Therapeutics to Host Investor Event on Nomlabofusp Program
Jun 27 2026
NASDAQ.COM
Larimar Therapeutics to Host Investor Event on Clinical Updates
Jun 26 2026
Newsfilter
Show More News
LRMR Events
No data
LRMR Monitor News
Larimar's Nomlabofusp Receives FDA Breakthrough Therapy Designation
Feb 25 2026
Larimar Therapeutics surges amid market gains
Feb 24 2026
LRMR Earnings Analysis
No Data
People Also Watch
